Funds and ETFs ResMed Inc. Australian S.E.

Equities

RMD

AU000000RMD6

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:44 2024-04-26 am EDT 5-day change 1st Jan Change
31.5 AUD +9.60% Intraday chart for ResMed Inc. +12.82% +23.82%

ETFs positioned on ResMed Inc.

Name Weight AuM 1st Jan change Investor Rating
0.39% 121 M€ -0.63% -
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
218.1 USD
Average target price
214.6 USD
Spread / Average Target
-1.59%
Consensus